Tenax Therapeutics (TENX) FCF Margin (2011 - 2015)

Tenax Therapeutics (TENX) has 4 years of FCF Margin data on file, last reported at 6810.14% in Q2 2015.

• For the quarter ending Q2 2015, FCF Margin changed N/A year-over-year to 6810.14%; the trailing twelve-month figure through Jun 2016 stood at 41810.97% (down 4144339.0% YoY), and the FY2015 full-year result was 19788.64%, down 1626333.0% from the prior year.
• FCF Margin fell to 6810.14% in Q2 2015, from 1092.97% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 221.61% in Q4 2012 to a low of 8257.17% in Q3 2011.
• A 4-year average of 2920.25% and a median of 1526.41% in 2012 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin soared 764730 bps in 2012 and surged 40167 bps in 2013, its largest moves.
• Tracing TENX's FCF Margin over 4 years: stood at 4756.36% in 2011, then soared by 95 bps to 221.61% in 2012, then slumped by 393 bps to 1092.97% in 2013, then sank by 523 bps to 6810.14% in 2015.
• Business Quant data shows TENX's FCF Margin at 6810.14% in Q2 2015, 1092.97% in Q2 2013, and 333.3% in Q1 2013.